Article info

Original article
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

Authors

  1. Correspondence to Dr Geneviève Inchauspé, Transgene SA, 321 Avenue Jean Jaures, Lyon 69007, France; inchauspe{at}transgene.fr
View Full Text

Citation

Martin P, Dubois C, Jacquier E, et al
TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice

Publication history

  • Received July 15, 2014
  • Revised October 4, 2014
  • Accepted October 20, 2014
  • First published November 26, 2014.
Online issue publication 
October 26, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.